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SUMMARY
Three enzyme immunoassays were used for the serodiagnosis of Trypan8osoma
evansi in camels in the Sudan in order to evaluate their ability to discriminate
between infected and non-infected animals. Two assays were used for the
detection of trypanosomal antibodies, one using specific anti-camel IgG conjugate
and another using a non-specific Protein A conjugate. The third assay detected the
presence of trypanosomal antigens using anti-T. evansi antibodies in a double
antibody sandwich assay. Inspection of the frequency distribution of assay results
suggested that the ELISA for circulating trypanosomal antibodies using specific
antisera and the ELISA for circulating antigens can distinguish between non-
infected camels and infected camels exhibiting patent infections or not. The
ELISA using Protein A conjugate to bind non-specifically to camel immuno-
globulin did not appear to discriminate between infected and non-infected
animals.
INTRODUCTION
Infections of livestock with Trypanosoma evansi occur in many countries in
Asia, northern Africa and Latin America. Trypanosomiasis in the camel (Camelus
dromedarius) has been recognized as an important disease of livestock in the Sudan
since the beginning of this century. According to a recent animal census (Boid,
Jones & Luckins, 1986), the camel population in Sudan was approximately 2-5
million, the majority of animals being in the eastern and western regions.
Dromedary camels are important to the nomadic peoples of Northern Sudan
because, in addition to providing food, transport and clothing, they also represent
personal wealth within the community. The province of Kassala supports a large
population of camels, and veterinarians there still rank trypanosomiasis as a
major threat to the camel industry.
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Control of the disease by drug treatment relies on effective diagnosis primarily
on parasitological techniques (Godfrey & Killick-Kendrick, 1962). In order to
improve diagnostic efficiency, several serological tests have been used to detect T.
evansi antibodies in the camel. These include the complement fixation test
(Schoening, 1924), indirect fluorescent antibody assays (Luckins et al. 1979) and
indirect haemagglutination tests (Wilson et al. 1983).
More recently, the enzyme-linked immunosorbent assay (ELISA) has been
developed for the detection of Trypanosoma spp. antibodies and antigens in
animal sera (Luckins & Mehlitz, 1978; Luckins et al. 1979; Rae & Luckins, 1984).
The ELISA is a test that is both analytically and diagnostically sensitive and
diagnostically specific. Interpretation of results can be quantitative and objective,
and the assay may be fully automated, so that large numbers of sera can be
screened (Ruitenberg et al. 1977).
The purpose of the present study was to evaluate the ability of three enzyme
immunoassays to discriminate between infected and non-infected camels, using
blood samples collected from camels in the Sudan over a 2-year period.
MATERIALS AND METHODS
Serum samples
A total of 944 serum samples was collected from camels (Camelus dromedarius)
in Kassala Province, Eastern Sudan, during the period January 1985 to December
1986. Eighteen serum samples were collected from police camels submitted for
their annual veterinary inspection during June and July 1985; 29 samples were
obtained from camels at a slaughterhouse in June 1985; the remaining 897
samples were collected from sick camels, possibly with trypanosomiasis, presented
by their owners at Kassala Veterinary Clinic. All sera were heat inactivated at
56 °C for 30 min before shipment to the Centre for Tropical Veterinary Medicine
for ELISA testing. 'Negative' control sera were collected from four camels kept
at Edinburgh Zoological Park, Scotland. These were also heat inactivated as
described.
Parasitological diagnosis
Venous blood samples were taken from the jugular vein and collected into
ethylenediaminetetra-acetic acid (EDTA) for parasitological examination. The
microhaematocrit centrifuge technique (Woo, 1970) was performed on all blood
samples for the identification of T. evansi infection.
Trypanosomes
Two stocks of Trypanosoma evansi were used in the preparation of antigens for
ELISA:
(1) T. brucei evansi, isolated from a naturally infected camel at Kassala
Province, Eastern Sudan, in 1977, and passaged in rats and mice before
cryopreservation as TREU 1418. This antigen was used in Tests 1 and 2;
(2) T. brucei evansi, isolated from a naturally infected ox at Bogor, Indonesia,
in 1984, and passaged in mice before being cloned and cryopreserved as
TREU 1942. This antigen was used for the production of rabbit anti-T.
evansi immune serum.
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Ten mice were infected with T. evansi and, after a fulminating parasitaemia had
developed, blood was collected. Blood was passed through a column of
diethylaminoethyl cellulose (Whatman, DE52) as described by Lanham &
Godfrey (1970), in order to separate parasites from blood elements. The
trypanosome suspension was centrifuged at 3200 g for 15 min, the supernate
discarded, and the resulting pellet washed three times in 100 mm phosphate-
buffered saline, pH 7-2 (PBS) by centrifugation at 2500 g for 15 min. The
trypanosomes were resuspended to 1-0 ml in PBS and the antigens prepared using
the method described by Luckins (1977). The protein content of each antigen
preparation was determined using BCA protein assay reagent (Pierce Chemical
Company). Antigens were subsequently stored at -79 °C until required.
Reagents for use in ELISA
Horseradish peroxidase-conjugated rabbit anti-camel IgO
Rabbit anti-camel IgG antiserum was prepared as described elsewhere (Boid
et al. 1980). Horseradish peroxidase (Type VI, Sigma) was conjugated to the
specific antiserum using the technique described by Wilson & Nakane (1978).
Conjugates in PBS containing 0-15 mm bovine serum albumin were sterilized by
filtration through a 0-22 ,um filter (Millipore) and stored at -20 °C until used.
Horseradish peroxidase-labelled staphylococcal Protein A
Conjugated protein A was obtained commercially (Sigma) in a lyophilized form.
After reconstitution according to the manufacturer's instructions, the conjugate
was divided into 50 ,1 amounts and stored at -20 'C.
Production of anti-T. evansi antiserum and conjugate
Adult male New Zealand White rabbits were used for the production of serum
against a sonicated T. evansi (TREU 1942) antigen preparation. The method
described by Thalhamer & Freund (1984) was applied. Briefly, 2 mg soluble
trypanosome protein (Luckins, 1977) were injected subcutaneously at day 0 and
again intramuscularly at day 7 and day 21. Following this, 5 mg of protein were
given subcutaneously at day 22 and intravenously at day 23. The first dose was
given with complete Freund's adjuvant (Difco), subsequent injections were given
in 140 mm sodium chloride. Antisera were collected 7 days after the last injection
and stored at -40 'C. The activity of the hyperimmune serum was analysed
against the soluble proteins obtained from TREU 1942 by SDS-PAGE and
standard immunoblotting techniques. At least 250 antigens were detected using
this antiserum (R. Boid, personal communication). The specific antibody content
of the serum was tested by ELISA (Luckins, 1986) using the same antigen
preparation.
An immunoglobulin fraction of the antiserum was obtained by precipitation
using ammonium sulphate, reconstitution in PBS and then extensive dialysis
against the same buffer. The protein concentration of the immunoglobulin fraction
was determined using BCA protein assay reagent (Pierce Chemical Company)
before conjugation with horseradish peroxidase (Rae & Luckins, 1984).
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Serological tests
For each ofthe enzyme immunoassays, optimal antigen, antibody and conjugate
dilutions were established by chequerboard titrations using 'negative' control
sera from uninfected camels at Edinburgh Zoo and 'positive' control sera selected
from camels with parasitologically proven T. evansi infections.
The three test assays were:
(1) a conventional ELISA test for detecting trypanosomal antibodies as
described by Luckins (1986) (Test 1);
(2) an assay using commercially available staphylococcal Protein A labelled
with horseradish peroxidase to detect primarily IgG class trypanosomal
antibodies (Zweygarth, Sabwa & Rottcher, 1986) (Test 2);
(3) a double antibody sandwich ELISA technique for detecting circulating
trypanosomal antigens (Luckins, 1986) (Test 3).
All three enzyme immunoassays were conducted using the substrate 3,3'5,5'-
tetramethylbenzidine (Sigma) as described by Luckins (1986). Plates were set to
zero absorbance using the PBS-T control wells.
Data recording
For each camel, data were recorded on:
(1) the presence or absence of patent infection, as determined by microscopic
examination of blood;
(2) the optical density values of the three ELISA tests;
(3) the month in which the camel was sampled.
Data were initially recorded on the 'PANACEA' database management system
(Pan Livestock Services, Department of Agriculture, University of Reading) on
an AMSTRAD PC1640 microcomputer, and were then moved to an AMDAHL
mainframe computer at the University of Edinburgh's Computer Service, where
they were inspected using the 'MINITAB' statistical package (Ryan, Joiner &
Ryan, 1985).
RESULTS
The results of the parasitological investigation showed that of the 944 camels
considered, 751 did not have patent infection and 193 had patent infection.
Histograms, illustrating various features of the distributions of the ELISA results,
are given in the figures. (Note that in a histogram the area, not the height, of a
particular rectangle is proportional to the number, or frequency, of observations
lying in the interval covered by the base of the rectangle. For the special case
where the rectangles all have equal base widths, that is, when all the class intervals
are of equal widths, the heights of the rectangles are proportional to the areas and
thus to the frequencies. For the more general case, as in this paper, where the
rectangles may have different base lengths, the height is represented as a
'frequency density', that is, as a frequency per unit measurement on the base line.
For example, in Fig. l b the unit measurement is taken to be 0 1 /A450 nm; other
figures have different unit measurements. This procedure ensures that the areas of
the rectangles are proportional to the appropriate class frequencies.) The effect on
the histograms of the removal of the results for those camels with ELISA values
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Fig. 1. Frequency distribution of results of ELISA tests for T. evansi in camels with
patent infection, November 1985 to December 1986. (In the first column, animals with
ELISA values greater than zero are plotted below the dotted line.) Number of camels,
193. (a) Conventional ELISA test for antibody to T. evan8i. (b) Protein A ELISA test
for antibody to T. evan8i. (c) ELISA test for T. evanBi antigens.
of zero (to two decimal places) is indicated by a dotted line in the left-hand bar of
each figure, values of zero being plotted above the dotted line.
Fig. 1 a-c depicts the distribution of the results of the three ELISAs from the
193 camels which had patent infection. In Fig. 1 a,b for those camels with ELISA
values greater than zero (to two decimal places), the shape of the histograms is
suggestive of the Normal. The shape of the histogram in Fig. 1 c, again for camels
with ELISA values greater than zero, is suggestive of a lognormal distribution.
The remaining Figs. (2a-4c) refer to camels without patent infection (i.e. camels
which are either non-patently infected or non-infected). No patent infections were
recorded in the first 10 months of the survey in a relatively large sample of 173
animals; this was therefore probably a time during which no current infections
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Fig. 2. Frequency distribution of results of ELISA tests for T. evansi in camels without
patent infection, January 1985 to December 1986. (In the first column, animals with
ELISA values greater than zero are plotted below the dotted line.) Number of camels,
751. (a) Conventional ELISA test for antibody to T. evan8i. (b) Protein A ELISA test
for antibody to T. evansi. (c) ELISA test for T. evan8i antigens.
were present. This serological survey therefore was divided into two distinct
periods:
(1) January to October 1985: during which no patent infections were
identified;
(2) November 1985 to December 1986: during which 193 infections were
detected in 771 camels sampled.
The relationships among Figs. 2a-4c are shown in Table 1. Fig. 2 a-c relates to
camels during the total study period (January 1985 to December 1986). The form
of the histogram in Fig. 2a suggests that the results of ELISA Test 1 for camels
with ELISA values greater than zero may be a mixture of two distributions:
exponential and Normal. The form of the histograms in Fig. 2b,c (representing
Tests 2 and 3, respectively, for camels with ELISA values greater than zero) is
indicative of an exponential distribution.
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Table 1. Figures representing histograms of test results for camels without patent
infection. The histograms of the figures listed in the fourth column are formed by
adding together the two histograms represented by the figures in parentheses
Study period*
1 2 3
3a 4a 2a (3a, 4a)
3b 4b 2b (3b, 4b)
3c 4c 2c (3c, 4c)
* 1, January 1985 to October 1985; 2, November 1985 to December 1986; 3, January 1985 to
December 1986.
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Fig. 3. Frequency distribution of results ofELISA tests for T. evansi in camels without
patent infection, January 1985 to October 1985. (In the first column, animals with
ELISA values greater than zero are plotted below the dotted line.) Number of camels,
173. (a) Conventional ELISA test for antibody to T. evansi. (b) Protein A ELISA test
for antibody to T. evansi. (c) ELISA test for T. evansi antigens.
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Fig. 4. Frequency distribution of results of ELISA tests for T. evansi in camels without
patent infection, November 1985 to December 1986. (In the first column, animals with
ELISA values greater than zero are plotted below the dotted line.) Number of camels,
578. (a) Conventional ELISA test for antibody to T. evansi. (b) Protein A ELISA test
for antibody to T. evansi. (c) ELISA test for T. evansi antigens.
Fig. 3a-c illustrates distributions of ELISA values during the initial 10-month
period of study (January to October 1985) when no patent infections were
identified. Fig. 3a,c, again for camels with ELISA values greater than zero,
suggests an exponential distribution. In contrast, Fig. 3b is similar to a Normal
distribution.
Fig. 4a-c shows frequency distributions of ELISA values for camels not
exhibiting patent infection during the second half of the study period (November
1985 to December 1986). It was during this period that all the patent infections
were identified. A mixture of an exponential and a Normal distribution (heavily
weighted towards the Normal) is suggested for animals with ELISA values greater
than zero in Fig. 4a. Fig. 4b indicates an exponential distribution, whereas Fig.
4c suggests a lognormal one (again, for animals with ELISA values greater than
zero).
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DISCUSSION
Diagnosis of trypanosomiasis in individual camels at risk from infection with T.
evansi is dependent on a number of factors: those relating to host-parasite
interaction including levels of parasitaemia and presence or absence of tryp-
anosomal antibodies, and those relating to the type of diagnostic test used,
particularly its detection limits. Hence, in chronic infections parasites may be few
in number and difficult to detect. In camels with active infections, examination of
blood microscopically fails to identify less than half of those animals shown to be
infected by rodent inoculation (Godfrey & Killick-Kendrick, 1962). Serological
assays may provide a convenient alternative to examination of blood films for
identification of infection with T. evansi. Previous surveys for trypanosomiasis in
camels have shown that in areas where the disease occurs large numbers of camels
show serological evidence of infection (Luckins et al. 1979). However, problems in
the interpretation of the results of serological assays such as ELISA tests means
that it is difficult to determine the infection status of individual animals.
Experimental evidence indicates the extent of these problems. Thus, in camels and
rabbits infected with T. evansi, antibodies appear within 14 days of infection and
remain throughout the duration of -the infection. Following treatment and
elimination of infection, although there is decline, antibodies persist in the
circulation for up to 100 days after treatment (Luckins, Gray & Rae, 1978;
Luckins et al. 1979). Antigens released by the parasites can be detected in serum
as early as 5 days after infection. After trypanocidal drug treatment, antigen is no
longer detectable 7 days after treatment (Rae & Luckins, 1984). Hence, whilst
both tests are capable of indicating the presence of trypanosomes, the test for
antigen detection seems capable of identifying animals with current infections,
which may be either patent or non-patent. Most work involving the use of ELISA
in animal trypanosomiasis has relied on the interpretation of results based on an
arbitrary absorbance value to distinguish between positive and negative results.
The data collected from this survey are being used to provide statistically valid
methods of interpretation and these preliminary investigations present the
frequency distributions of the three immunoassays.
Two probability distributions (an exponential, and a Normal and related
distribution - the lognormal) are suggested by the Figures. An exponential
distribution would be considered consistent with the decay of antibodies
stimulated by a previous infection, in the absence of current infection. Recently
stimulated antibodies, along with many other biological variables, are Normally
distributed, or their distribution can be transformed to Normality. Antibodies
accompanying current infection frequently follow such a pattern (e.g. Herbert,
1970). Identification of these two different patterns (exponential or Normal) may
therefore allow definition of an animal as being either currently infected or
uninfected (either with or without waning antibody levels resulting from previous
infection).
The distribution of ELISA values for Tests 1-3 in patently infected animals (Fig
1 a-c) is consistent with their current infection. Fig. 3a,c shows exponential
distributions, consistent with both antibody and antigen decay in the absence of
current infection. Tests 1 and 3 thus appear to reflect accurately an animal's
infection status; either infected or non-infected. However, the histogram
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representing the results of Test 2 (Fig. 3b) is similar to that depicted in Fig. lb
relating to camels with patent infection. Thus, Test 2 is not good at discriminating
between camels with and without current infection.
The second period (November 1985 to December 1986) was characterized by
both patently and not-patently infected animals and therefore may have included
animals with ELISA values resulting from both current and previous infections.
Furthermore, camels that are not patently infected may have non-patent
infections: Godfrey & Killick-Kendrick (1962) showed that approximately 60% of
camels without patent infections are non-patently infected. Fig. 4af-c thus relates
to camels which may, or may not, be non-patently infected, in the approximate
ratio of 6:4 respectively. Test 1 (Fig. 4a) implies current infection (a Normal
distribution) and previous infection with waning antibody levels (an exponential
distribution), with the two distributions clearly separated, and could thus be used
to identify current infection (patent or non-patent). Fig. 2 a, depicting the results
of this test for the full study period, substantiates this inference. Test 2 (Fig. 4b)
does not display a Normal component and therefore is unsuitable for detecting
current infections. In contrast, Test 3 (Fig. 4c) has a lognormal distribution. This
can be transformed to a Normal one and therefore may be suitable for identifying
current infections, either patent or non-patent.
This investigation of three ELISAs suggests that the test for circulating
antibody (Test 1) is likely to be the best test for differentiating between non-
infected and infected (either patently or non-patently) camels. Test 3 is also
capable of identifying infection.
Further work is required to determine the best fit of a statistical distribution to
the continuous data that result from the tests. It appears from the histograms that
this fit will be achieved by consideration of exponential, Normal and lognormal
distributions.
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